Toxicogenomics and proteomics / Editores, James J. Valdes, Jennifer W. Sekowski.
Tipo de material:![Texto](/opac-tmpl/lib/famfamfam/BK.png)
- 1586034022
- RA1220.3 .T6 2004
Tipo de ítem | Biblioteca actual | Colección | Signatura topográfica | Copia número | Estado | Notas | Fecha de vencimiento | Código de barras | |
---|---|---|---|---|---|---|---|---|---|
![]() |
Biblioteca Magna a | Acervo General | RA1220.3 .T6 2004 | Disponible | 080885 | ||||
![]() |
Biblioteca Magna a | Acervo General | RA1220.3 .T6 2004 | V. 1 Ej. 02 | Disponible | 080884 | |||
![]() |
Biblioteca Magna a | Acervo General | RA1220.3 .T6 2004 | V. 1 Ej. 01 | Disponible | Préstamo interno (etiqueta naranja) | 079646 |
Incluye referencias bibliográficas. .
Cap. 1. Systems biology.-- Cap. 2. The Role of bioninformatics in toxicogenomics and proteomics.-- Cap. 3. Interpretaation of global gene expression data through gene ontologies.-- Cap. 4. Expanding the information window to increase proteomic sensitivity and selectivity.-- Cap. 5. Understanding the significance of genetic variability in the human PON1 gene.-- Cap. 6. Functional genomics methods in hepatotoxicity.-- Cap. 7. The toxicogenomics of low-level exposure to organophosphate nerve agents.-- Capítulo 8. Molecular biomarkers.-- Cap. 9. Expressión profiling of sulfur mustard exposure inmurine skin: chemokines, cytokines and growth factors.-- Cap. 10. Further progress in DNA repair puzzle in the postgenomics era.-- Cap. 11. Non-Ribosomal peptide synthetases for the production of bioactive peptides with syringomycin synthetase as an example.